The metabolic profile of tumors depends on both the responsible genetic lesion and tissue type.
about
Links between metabolism and cancerFundamentals of cancer metabolismTargeting metabolism in breast cancer: How far we can go?Cancer Metabolism: A Modeling PerspectiveIntegration of Mitochondrial Targeting for Molecular Cancer TherapeuticsNanodiamonds: The intersection of nanotechnology, drug development, and personalized medicineHyperpolarized (13)C Magnetic Resonance and Its Use in Metabolic Assessment of Cultured Cells and Perfused OrgansMYC, Metabolism, and CancerFunctional interactions among members of the MAX and MLX transcriptional network during oncogenesisThe genetic and epigenetic alterations in human hepatocellular carcinoma: a recent updateRedox control of glutamine utilization in cancerGlutamine and cancer: cell biology, physiology, and clinical opportunitiesTargeting mitochondrial metabolism by inhibiting autophagy in BRAF-driven cancersDeficiency for the cysteine protease cathepsin L impairs Myc-induced tumorigenesis in a mouse model of pancreatic neuroendocrine cancerActive Glutaminase C Self-assembles into a Supratetrameric Oligomer That Can Be Disrupted by an Allosteric InhibitorMetabolic rewiring in melanomaROS homeostasis and metabolism: a critical liaison for cancer therapyMetabolic pathways promoting cancer cell survival and growthApplication of Holistic Liquid Chromatography-High Resolution Mass Spectrometry Based Urinary Metabolomics for Prostate Cancer Detection and Biomarker DiscoveryProteomic analysis of pRb loss highlights a signature of decreased mitochondrial oxidative phosphorylationLoss of RBF1 changes glutamine catabolismPyruvate carboxylase is critical for non-small-cell lung cancer proliferation.Mitochondrial complex I inhibition triggers a mitophagy-dependent ROS increase leading to necroptosis and ferroptosis in melanoma cellsNon-invasive metabolic imaging of brain tumours in the era of precision medicine.O-GlcNAcylation: The Sweet Side of the Cancer.From Krebs to clinic: glutamine metabolism to cancer therapy.A joint analysis of metabolomics and genetics of breast cancer.Hominoid-specific enzyme GLUD2 promotes growth of IDH1R132H gliomaA phase I study of the first-in-class antimitochondrial metabolism agent, CPI-613, in patients with advanced hematologic malignancies.Upregulated SLC1A5 promotes cell growth and survival in colorectal cancerReconstruction of genome-scale metabolic models for 126 human tissues using mCADRECerebral Gluconeogenesis and Diseases.Regulation of glucose metabolism in hepatocarcinogenesis by microRNAs.Drosophila Myc: A master regulator of cellular performance.Gain of glucose-independent growth upon metastasis of breast cancer cells to the brainIn vivo analysis of lung cancer metabolism: nothing like the real thing.Deregulated Myc requires MondoA/Mlx for metabolic reprogramming and tumorigenesisBoth GLS silencing and GLS2 overexpression synergize with oxidative stress against proliferation of glioma cells.Stable isotope-labeled tracers for metabolic pathway elucidation by GC-MS and FT-MS.Famine versus feast: understanding the metabolism of tumors in vivo.
P2860
Q24626229-6E30B9FD-E8A2-421E-83DA-E565626B03DBQ26744062-2B89B36A-63EC-4589-B17F-E29C5F73232DQ26767022-BBAEF901-68E1-4C47-AFFE-72D7C1F8737AQ26770819-C2ADF789-B186-432D-842B-634BA0B44B15Q26771751-2333066E-4AD9-49C8-9EB1-DA2C8586D514Q26776095-69B8A90F-9144-476F-9C9F-AAD1FC56125AQ26781659-66AB277F-7B1A-4254-AB5D-6A151BEF0B05Q26783555-9E5D8597-FE42-4AAE-B68A-E2420864E6C5Q26853567-AD4B9332-812D-4143-916C-DFE08F79F889Q27003050-385FF363-5D6F-428A-BD58-8CC666325059Q27005615-892C9CD0-E859-4832-80D4-757313AF61EFQ27011818-427E489F-706F-47F9-9617-F90CA9BB3A45Q27022240-C1C87098-ECC9-44B1-AF2C-33235673B70AQ27311493-438CB146-9F67-436E-87ED-9C17598B5DB5Q27679516-9BB40060-3F82-4DCB-9FE4-BA0EE9F99AADQ28069081-C8730017-0EDF-4E97-B64C-359AFA33FFBEQ28080316-DE76920D-6FBE-43D7-91E2-925FB4B7D5AEQ28086940-4CF0BD42-B2E9-4F97-A1E4-88822F4B715FQ28534070-E8C497F0-AF6B-463D-8F43-5EF899C1EF28Q28607552-AE485A32-9E3C-4D3B-AAAD-FB7A67E871E5Q28709122-E1CF8707-4E04-496F-81D2-7E2E12402D43Q30619793-146068DA-81F7-44EE-AD26-C00C751D114BQ30844792-E315558E-F84F-455D-827C-49D82DF90DABQ31115540-25A8DDAD-D5DF-46B1-826A-D0C26F3F0A19Q33701447-9B6D21EA-98AF-45BD-9772-E0B55F125906Q33834498-84BCF1DE-7F10-4843-9682-C75421B896EBQ34296486-91838758-A6BB-41EA-82DE-27F1D537B3EEQ34314291-5C60B9EA-1FAF-4864-9B0B-F7DB02A50156Q34353111-4806146E-7656-4F9F-A4D8-95DE765E9C06Q34371526-6345E8C4-E840-4B66-B203-028120C422FEQ34509501-4B8DFA04-E317-471A-9731-F2A74AB30AC4Q34549622-C65D7B7F-8570-4C0B-A183-747E002B6305Q34803043-03A7597A-618F-433D-BDA4-FD38D54A2C5CQ34873737-B2DA5219-10C2-4130-95E8-FCD3C7582BB4Q35044463-3F1ED96B-851F-481D-A534-966B47B3BA8AQ35056764-017A37C0-53BA-4B39-8660-26F71647345CQ35079601-1C4F6DE0-18D2-4DE0-96C0-6DD64EC6D999Q35083218-B42EF4F2-E3A4-422F-BEBC-5424D1767F8BQ35109445-441D29E7-2021-4AD0-B8FB-F5F24470A174Q35122371-5F40DF15-098C-4ABC-B402-13B2B479376F
P2860
The metabolic profile of tumors depends on both the responsible genetic lesion and tissue type.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
The metabolic profile of tumor ...... enetic lesion and tissue type.
@ast
The metabolic profile of tumor ...... enetic lesion and tissue type.
@en
type
label
The metabolic profile of tumor ...... enetic lesion and tissue type.
@ast
The metabolic profile of tumor ...... enetic lesion and tissue type.
@en
prefLabel
The metabolic profile of tumor ...... enetic lesion and tissue type.
@ast
The metabolic profile of tumor ...... enetic lesion and tissue type.
@en
P2093
P2860
P50
P1433
P1476
The metabolic profile of tumor ...... genetic lesion and tissue type
@en
P2093
Francisco J Alonso
J Michael Bishop
Mariia O Yuneva
Richard M Higashi
Takashi Tsukamoto
Teresa W M Fan
Thaddeus D Allen
Youngho Seo
P2860
P304
P356
10.1016/J.CMET.2011.12.015
P577
2012-02-01T00:00:00Z